SCHEMBL8901942

SCHEMBL8901942

CCOC(=O)C1Cc2c(O)c3c(c(O)c2CO1)C(=O)c1ccccc1C3=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 6/20 0.41
MAPT P10636 4/20 0.41
APAF1 O14727 1/20 0.41
MITF O75030 1/20 0.41
CHRM1 P11229 1/20 0.38
TBXA2R P21731 1/20 0.38
PTGS1 P23219 1/20 0.38
ADRA1A P35348 1/20 0.38
CYP1A2 P05177 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 1/20 0.37
TDP1 Q9NUW8 3/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
CYP3A4 P08684 1/20 0.36
IDO1 P14902 1/20 0.36
MAPK1 P28482 1/20 0.36
HBB P68871 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8901847 0.83 CHRM1 (0.41) SMN1; SMN2LMNAALDH1A1MAPTMITF
SCHEMBL9755757 0.82 MAPT (0.41) SMN1; SMN2ALDH1A1MAPTAPAF1MITF
SCHEMBL8901644 0.71 CTDSP1 (0.44) ALDH1A1ADRA1ACYP1A2TSHRTDP1
SCHEMBL9755776 0.71 MAPT (0.37) SMN1; SMN2LMNAALDH1A1MAPTMITF
SCHEMBL8901512 0.70 NQO1 (0.36) ALDH1A1MAPTCYP1A2CYP2C19MAPK1
SCHEMBL8903420 0.70 KDM4E (0.35) SMN1; SMN2LMNAALDH1A1MAPTCYP1A2
SCHEMBL8901797 0.70 KDM4E (0.35) SMN1; SMN2LMNAALDH1A1MAPTCYP1A2
SCHEMBL21847501 0.69 ALDH1A1 (0.41) ALDH1A1MAPTTSHRGAAKDM4E
SCHEMBL8901951 0.67 CHRM1 (0.38) SMN1; SMN2LMNAALDH1A1MAPTAPAF1
SCHEMBL8903879 0.67 KDM4E (0.36) SMN1; SMN2ALDH1A1MAPTCYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed